LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
BT-20 SU11274
10.0
uM
LJP5
 72
hr
 1657 2093 5505 0.3803 0.1133
BT-20 Fedratinib
10.0
uM
LJP5
 72
hr
 1657 1702 5505 0.3091 0.0115
BT-20 TGX221
10.0
uM
LJP5
 72
hr
 1657 5980 5505 1.0862 1.1234
BT-20 Torin1
10.0
uM
LJP6
 72
hr
 1657 1080 5505 0.1962 -0.1501
BT-20 Torin2
10.0
uM
LJP5
 72
hr
 1657 1242 5505 0.2257 -0.1080
BT-20 Tozasertib
10.0
uM
LJP5
 72
hr
 1657 1660 5505 0.3016 0.0007
BT-20 Trametinib
10.0
uM
LJP5
 72
hr
 1657 4343 5505 0.7888 0.6979
BT-20 TWS119
10.0
uM
LJP5
 72
hr
 1657 1933 5505 0.3512 0.0716
BT-20 Vemurafenib
10.0
uM
LJP5
 72
hr
 1657 3848 5505 0.6989 0.5692
BT-20 Withaferin A
10.0
uM
LJP5
 72
hr
 1657 933 5505 0.1695 -0.1883
BT-20 Withaferin A
10.0
uM
LJP6
 72
hr
 1657 931 5505 0.1692 -0.1887
BT-20 WYE-125132
10.0
uM
LJP6
 72
hr
 1657 2019 5505 0.3668 0.0940
BT-20 WZ3105
10.0
uM
LJP5
 72
hr
 1657 1126 5505 0.2046 -0.1380
BT-20 XMD11-50
10.0
uM
LJP6
 72
hr
 1657 2366 5505 0.4299 0.1842
BT-20 Y39983
10.0
uM
LJP6
 72
hr
 1657 2245 5505 0.4079 0.1528